Open AccessImproving The Treatment Of Paradontic Diseases With The Help Of Immunomodulating And Probiotic Drugs
Author(s) -
Rizayev Jasur Alimjanovich,
Nazarova Nodira Sharipovna,
Nasreddinova Maxzuna Taxsinovna
Publication year - 2021
Publication title -
the american journal of medical sciences and pharmaceutical research
Language(s) - English
Resource type - Journals
ISSN - 2689-1026
DOI - 10.37547/tajmspr/volume03issue08-08
Subject(s) - oral cavity , probiotic , antibody , secretory iga , etiology , immunology , medicine , monoclonal antibody , biology , pathology , dentistry , bacteria , genetics
Parodontitis is one of the most common types of dental pathology. Many factors play a role in the emergence and development of this disease. Despite certain achievements in the study of the etiological and pathogenetic ome and in the development of parodontitis diagnostics and methods of treatment of Ome, its emergence and development have not yet been determined to the end. The emergence and passage of parodontitis is accompanied by significant changes in the content of humoral factors in the oral fluid: IgA, which plays a leading role in the defense of the mucous membrane of the oral cavity, immunoglobulins of IgG classes and secretory immunoglobulins - slgA; albumin, whose concentration in the oral fluid increases as a result of increasing the permeability of the walls